Medical Advisory Board
Dr. Kenneth R. Chapman
M.D., M.Sc., FRCPC, FACP, FCCP
Dr. Chapman is a Professor of Medicine at the University of Toronto and an internationally respected researcher in the field of asthma and airway diseases. Dr. Chapman is also Director of the Canadian Registry for Alpha-1 Antitrypsin Deficiency.
Dr. Jean Bourbeau
Dr. Bourbeau is associate professor in the Department of Medicine and the Department of Epidemiology and Biostatistics and Occupational Health at McGill University.
Dr. Simon Ling
Dr. Ling is Associate Professor of Paediatrics at the Hospital for Sick Children, University of Toronto. Additionally, Dr. Ling collaborates in studies of the genetic determinants of liver disease due to cystic fibrosis and alpha-1 antitrypsin deficiency.
Dr. Marsha Speevak
B.Sc., PhD, FCCMG, FACMG
Dr. Speevak is Assistant Professor, University of Toronto, Department of Laboratory Medicine and Pathobiology. Dr. Speevak’s laboratory at Credit Valley Hospital provides targeted genotyping (S and Z variants) as well as full gene sequencing of SERPINA1, the gene responsible for alpha-1-antitrypsin deficiency.
Dr. David Wong
M.D., FRCP (C)
Dr. Wong is a Hepatologist at Toronto Western Hospital, Toronto General Hospital and St Michael’s. He has an interest in viral hepatitis and non-invasive markers for assessment of liver fibrosis and cirrhosis.